140 related articles for article (PubMed ID: 27997807)
1. Roflumilast N-Oxide in Combination with Formoterol Enhances the Antiinflammatory Effect of Dexamethasone in Airway Smooth Muscle Cells.
Patel BS; Rahman MM; Baehring G; Xenaki D; Tang FS; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):532-538. PubMed ID: 27997807
[TBL] [Abstract][Full Text] [Related]
2. Theophylline Represses IL-8 Secretion from Airway Smooth Muscle Cells Independently of Phosphodiesterase Inhibition. Novel Role as a Protein Phosphatase 2A Activator.
Patel BS; Rahman MM; Rumzhum NN; Oliver BG; Verrills NM; Ammit AJ
Am J Respir Cell Mol Biol; 2016 Jun; 54(6):792-801. PubMed ID: 26574643
[TBL] [Abstract][Full Text] [Related]
3. Inhibitors of Phosphodiesterase 4, but Not Phosphodiesterase 3, Increase β2-Agonist-Induced Expression of Antiinflammatory Mitogen-Activated Protein Kinase Phosphatase 1 in Airway Smooth Muscle Cells.
Patel BS; Prabhala P; Oliver BG; Ammit AJ
Am J Respir Cell Mol Biol; 2015 May; 52(5):634-40. PubMed ID: 25296132
[TBL] [Abstract][Full Text] [Related]
4. Doxofylline does not increase formoterol-induced cAMP nor MKP-1 expression in ASM cells resulting in lack of anti-inflammatory effect.
Patel BS; Kugel MJ; Baehring G; Ammit AJ
Pulm Pharmacol Ther; 2017 Aug; 45():34-39. PubMed ID: 28414142
[TBL] [Abstract][Full Text] [Related]
5. Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease.
Milara J; Lluch J; Almudever P; Freire J; Xiaozhong Q; Cortijo J
J Allergy Clin Immunol; 2014 Aug; 134(2):314-22. PubMed ID: 24636089
[TBL] [Abstract][Full Text] [Related]
6. Additive anti-inflammatory effects of beta 2 adrenoceptor agonists or glucocorticosteroid with roflumilast in human peripheral blood mononuclear cells.
Tannheimer SL; Sorensen EA; Haran AC; Mansfield CN; Wright CD; Salmon M
Pulm Pharmacol Ther; 2012 Apr; 25(2):178-84. PubMed ID: 22306235
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E
Bradbury P; Patel BS; Cidem A; Nader CP; Oliver BG; Ammit AJ
Inflamm Res; 2019 May; 68(5):369-377. PubMed ID: 30852628
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of the relaxant effects of roflumilast on human bronchus: potentiation by a long-acting beta-2-agonist.
Salvator H; Naline E; Brollo M; Tenor H; Grassin-Delyle S; Devillier P
Fundam Clin Pharmacol; 2021 Aug; 35(4):725-731. PubMed ID: 33145785
[TBL] [Abstract][Full Text] [Related]
9. Roflumilast partially reverses smoke-induced mucociliary dysfunction.
Schmid A; Baumlin N; Ivonnet P; Dennis JS; Campos M; Krick S; Salathe M
Respir Res; 2015 Oct; 16():135. PubMed ID: 26521141
[TBL] [Abstract][Full Text] [Related]
10. Roflumilast inhibits leukocyte-platelet interactions and prevents the prothrombotic functions of polymorphonuclear leukocytes and monocytes.
Totani L; Amore C; Di Santo A; Dell'Elba G; Piccoli A; Martelli N; Tenor H; Beume R; Evangelista V
J Thromb Haemost; 2016 Jan; 14(1):191-204. PubMed ID: 26484898
[TBL] [Abstract][Full Text] [Related]
11. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.
Tannheimer SL; Wright CD; Salmon M
Respir Res; 2012 Mar; 13(1):28. PubMed ID: 22452977
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase 4 Inhibitors Attenuate the Asthma Phenotype Produced by β2-Adrenoceptor Agonists in Phenylethanolamine N-Methyltransferase-Knockout Mice.
Forkuo GS; Kim H; Thanawala VJ; Al-Sawalha N; Valdez D; Joshi R; Parra S; Pera T; Gonnella PA; Knoll BJ; Walker JK; Penn RB; Bond RA
Am J Respir Cell Mol Biol; 2016 Aug; 55(2):234-42. PubMed ID: 26909542
[TBL] [Abstract][Full Text] [Related]
13. Long-acting β2-agonists increase fluticasone propionate-induced mitogen-activated protein kinase phosphatase 1 (MKP-1) in airway smooth muscle cells.
Manetsch M; Rahman MM; Patel BS; Ramsay EE; Rumzhum NN; Alkhouri H; Ge Q; Ammit AJ
PLoS One; 2013; 8(3):e59635. PubMed ID: 23533638
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.
Milara J; Morell A; Ballester B; Sanz C; Freire J; Qian X; Alonso-Garcia M; Morcillo E; Cortijo J
Respir Res; 2015 Feb; 16(1):12. PubMed ID: 25652132
[TBL] [Abstract][Full Text] [Related]
15. Roflumilast N-oxide prevents cytokine secretion induced by cigarette smoke combined with LPS through JAK/STAT and ERK1/2 inhibition in airway epithelial cells.
Victoni T; Gleonnec F; Lanzetti M; Tenor H; Valença S; Porto LC; Lagente V; Boichot E
PLoS One; 2014; 9(1):e85243. PubMed ID: 24416369
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterase 4 inhibitors augment the ability of formoterol to enhance glucocorticoid-dependent gene transcription in human airway epithelial cells: a novel mechanism for the clinical efficacy of roflumilast in severe chronic obstructive pulmonary disease.
Moodley T; Wilson SM; Joshi T; Rider CF; Sharma P; Yan D; Newton R; Giembycz MA
Mol Pharmacol; 2013 Apr; 83(4):894-906. PubMed ID: 23389862
[TBL] [Abstract][Full Text] [Related]
17. Roflumilast inhibits lipopolysaccharide-induced tumor necrosis factor-α and chemokine production by human lung parenchyma.
Buenestado A; Chaumais MC; Grassin-Delyle S; Risse PA; Naline E; Longchampt E; Tenor H; Devillier P
PLoS One; 2013; 8(9):e74640. PubMed ID: 24066150
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroid-Induced MKP-1 Represses Pro-Inflammatory Cytokine Secretion by Enhancing Activity of Tristetraprolin (TTP) in ASM Cells.
Prabhala P; Bunge K; Ge Q; Ammit AJ
J Cell Physiol; 2016 Oct; 231(10):2153-8. PubMed ID: 26825339
[TBL] [Abstract][Full Text] [Related]
19. Prostanoid Receptors of the EP
Joshi R; Hamed O; Yan D; Michi AN; Mostafa MM; Wiehler S; Newton R; Giembycz MA
J Pharmacol Exp Ther; 2021 Feb; 376(2):161-180. PubMed ID: 33158942
[TBL] [Abstract][Full Text] [Related]
20. A phosphodiesterase 4 inhibitor, roflumilast N-oxide, inhibits human lung fibroblast functions in vitro.
Sabatini F; Petecchia L; Boero S; Silvestri M; Klar J; Tenor H; Beume R; Hatzelmann A; Rossi GA
Pulm Pharmacol Ther; 2010 Aug; 23(4):283-91. PubMed ID: 20226872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]